BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38066434)

  • 1. A radiomics based method for prediction of prostate cancer Gleason score using enlarged region of interest.
    Zhuang H; Chatterjee A; Fan X; Qi S; Qian W; He D
    BMC Med Imaging; 2023 Dec; 23(1):205. PubMed ID: 38066434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.
    Gondo T; Hricak H; Sala E; Zheng J; Moskowitz CS; Bernstein M; Eastham JA; Vargas HA
    Eur Radiol; 2014 Dec; 24(12):3161-70. PubMed ID: 25100337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
    Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
    Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final Gleason score prediction using discriminant analysis and support vector machine based on preoperative multiparametric MR imaging of prostate cancer at 3T.
    Citak-Er F; Vural M; Acar O; Esen T; Onay A; Ozturk-Isik E
    Biomed Res Int; 2014; 2014():690787. PubMed ID: 25544944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
    Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
    Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of prostate cancer using texture analysis for diagnostic and prognostic monitoring.
    Singh D; Kumar V; Das CJ; Singh A; Mehndiratta A
    NMR Biomed; 2021 Jun; 34(6):e4495. PubMed ID: 33638244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer.
    Wang Y; Yu B; Zhong F; Guo Q; Li K; Hou Y; Lin N
    Magn Reson Imaging; 2019 Jul; 60():76-84. PubMed ID: 30917943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
    Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
    Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists.
    Antonelli M; Johnston EW; Dikaios N; Cheung KK; Sidhu HS; Appayya MB; Giganti F; Simmons LAM; Freeman A; Allen C; Ahmed HU; Atkinson D; Ourselin S; Punwani S
    Eur Radiol; 2019 Sep; 29(9):4754-4764. PubMed ID: 31187216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.
    Nketiah G; Elschot M; Kim E; Teruel JR; Scheenen TW; Bathen TF; Selnæs KM
    Eur Radiol; 2017 Jul; 27(7):3050-3059. PubMed ID: 27975146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of quantitative parameters and radiomic features as inputs into machine learning models to predict the Gleason score of prostate cancer lesions.
    Nai YH; Cheong DLH; Roy S; Kok T; Stephenson MC; Schaefferkoetter J; Totman JJ; Conti M; Eriksson L; Robins EG; Wang Z; Chua WY; Ang BWL; Singha AK; Thamboo TP; Chiong E; Reilhac A
    Magn Reson Imaging; 2023 Jul; 100():64-72. PubMed ID: 36933775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.
    Sadinski M; Karczmar G; Peng Y; Wang S; Jiang Y; Medved M; Yousuf A; Antic T; Oto A
    AJR Am J Roentgenol; 2016 Sep; 207(3):592-8. PubMed ID: 27352026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.
    Fehr D; Veeraraghavan H; Wibmer A; Gondo T; Matsumoto K; Vargas HA; Sala E; Hricak H; Deasy JO
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6265-73. PubMed ID: 26578786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
    Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
    [No Abstract]   [Full Text] [Related]  

  • 17. Peritumoral Radiomics Strategy Based on Ensemble Learning for the Prediction of Gleason Grade Group of Prostate Cancer.
    Qiu Y; Liu YF; Shu X; Qiao XF; Ai GY; He XJ
    Acad Radiol; 2023 Sep; 30 Suppl 1():S1-S13. PubMed ID: 37393175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI.
    Khanfari H; Mehranfar S; Cheki M; Mohammadi Sadr M; Moniri S; Heydarheydari S; Rezaeijo SM
    BMC Med Imaging; 2023 Nov; 23(1):195. PubMed ID: 37993801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninferiority of Monoparametric MRI Versus Multiparametric MRI for the Detection of Prostate Cancer: Diagnostic Accuracy of ADC Ratios Based on Advanced "Zoomed" Diffusion-Weighted Imaging.
    Raczeck P; Frenzel F; Woerner T; Graeber S; Bohle RM; Ziegler G; Buecker A; Schneider GK
    Invest Radiol; 2022 Apr; 57(4):233-241. PubMed ID: 34743133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy.
    Sadoughi N; Krishna S; McInnes MDF; Flood TA; Breau RH; Morash C; Schieda N
    AJR Am J Roentgenol; 2018 Sep; 211(3):W158-W165. PubMed ID: 29995495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.